Dorwest Herbs has launched its annual 'Dorwest Say Relax' fireworks phobia campaign, which includes free promotional packs for practices.
The promotional packs, which contain a poster, leaflets, flashing badges and a 'Dorwest Say Relax' t-shirt, being given free to the first 100 practices that request a product box (containing licensed Scullcap & Valerian Tablets and Organic Valerian Compound at a discounted price) from the company.
In addition, Dorwest is running a seemingly popular consumer facebook competition to find the most relaxed dog in the nation, the winner of which will be sent on a pet-friendly luxury weekend break.
Finally, the company is writing a blog written from the perspective of Merlin, the dog used in its logo - http://merlintakescontrol.wordpress.com - though quite who is going to read it, or why, is slightly beyond me.
Royal Canin has announced it is to launch Catom, a piece of software developed to help educate cat owners during veterinary consultations, at this year's London Vet Show.
Initially, the software will be available for PC and Mac, with iPad and Android versions coming by the end of the year.
You can can find out more by visiting Royal Canin's stand at the London Vet Show, where the company says it will have a large touch-screen TV displaying the software, along with laptop demos running throughout the exhibition.
Animalcare has released further information about Vitofyllin (propentofylline), its new CNS stimulant for dogs.
According to the company, Vitofyllin helps restore vitality and willingness to exercise, especially in the senior dog, by improving peripheral and cerebral vascular blood circulation. It is indicated to help improve dullness, lethargy and overall demeanour in dogs. In addition it has a bronchodilatory activity equivalent to amilophylline (a salt of theophylline)
Animalcare says that with dogs living longer, age-related problems are on the increase. The company highlights the example of Cognitive Dysfunction Syndrome (CDS), a neurodegenerative disease that affects older dogs. CDS is characterised by various pathological processes with signs that include disorientation, changing interaction with people or other pets, sleep-wake cycle alterations, soiling in the house and decreased activity levels.
The company says these subtle behavioural changes are unlikely to be picked up at a routine annual check. Indeed, in one study 75% of owners of dogs aged over 7 reported at least one behavioural sign consistent with CDS, however only 12% reported their concerns to a vet.2
Vitofyllin is available in 50mg and 100mg strengths in blister packs containing 56 tablets. Presented as 'easy to administer' four-way split cross-snap-tabs which can be divided into halves or quarters to enable more accurate dosing to be achieved whatever the weight of animal, even down to 2.5kg bodyweight.
Vitofyllin is POM-V licensed and has a 3 year shelf-life. Waiting room posters and client leaflets are available to support recognition of behavioural signs by clients and practice staff.
Further iinformation, and details about a special launch offer are available from local Animalcare representatives.
Reference
The Blue Cross has presented Sam Shand of Lincolnshire with the Veterinary Nurse of the Year award.
Sam scooped the title for her outstanding dedication to animal welfare and for her charity work. Sam, a vet nurse at Quarrington Veterinary Surgery in Sleaford, uses her free time to educate children and raise money for several local charities.
The award was presented during the BVNA Congress in Telford, Shropshire by BVNA President, Claire Fraser and Stephanie Byers, Blue Cross community vet nurse.
Wendy Adams, Blue Cross head of veterinary services said: "Blue Cross has been dedicated to the health and happiness of pets since 1897 and our award recognises the hard work and commitment of vet nurses across the UK. They are the unsung heroes of animal welfare and many of them go the extra mile, working tirelessly to look after sick and injured pets and educate their communities about animal care. Congratulations to Sam who really deserves to be this year's winner."
Sam was nominated by her colleagues at Quarrington Veterinary Surgery. Helen Fry, practice manager at the practice said: "Sam is passionate about caring for animals and her enthusiasm for their welfare reaches beyond the surgery. Sam works tirelessly to look after the animals in our care and still has the energy to use her free time to educate youngsters and fundraise for numerous charities. She is currently compiling a book of animal stories to teach children about pet care. We are so very proud that she has won this award."
Sam said: "When I heard that I was this year's winner I was completely gobsmacked. The news came totally out-of-the-blue and I was very moved and even quite tearful! It is so nice to get this recognition, not just for me but for all of the practice."
Two veterinary surgeons from the Animal Health Trust have won international awards for outstanding work in diagnostic imaging at 16th International Veterinary Radiology Association (IVRA) meeting held in Bursa Turkey.
Dr Sue Dyson, Head of Clinical Orthopaedics at the AHT, was awarded the IVRA J Kevin Kealy Award, which recognises members of the IVRA who have made substantial, scientific contributions to veterinary radiology.
The Award, established in 2003, is named in honour of Emeritus Professor J. Kevin Kealy, organiser of the first meeting of the IVRA, the first President, and an Honorary Member of the Association.
Sue has lectured internationally and published more than 200 refereed papers in scientific journals, as well as being a major author and editor of four books. On receiving the award, she said: "I was hugely surprised to receive this award and feel extremely honoured."
Past president of the IVRA, Peter Lord, said: "It is hard to imagine that equine diagnostic imaging today would be the same without the contributions of Sue Dyson and her colleagues. She is an outstanding recipient of the J Kevin Kealy Award."
Ruth Dennis, Head of Diagnostic Imaging (pictured above right), was awarded the European Association of Veterinary Diagnostic Imaging (EAVDI) Douglas and Williamson Award, established in 1983, to recognise outstanding achievement within the field of veterinary diagnostic imaging.
Ruth was President of the EAVDI between 2000 and 2002 and her long standing contributions to the association have been recognised with this award.
Ruth said: "I am very honoured to receive this award, especially since, as a vet student in Cambridge in the late 1970s, I was taught by Sidney Douglas and David Williamson, who were pioneers of veterinary radiology."
Nuria Corzo-Menendez, current EAVDI President, said: "Ruth's contributions to veterinary diagnostic imaging are vast and we will always be grateful for such great additions to our field."
Royal Canin has announced the launch of its Christmas promotion through which practice clients will be rewarded with activity balls for cats and leashpods for dogs.
The stocking fillers will be distributed to practices along with promotional materials such as posters and shelf wobblers, to encourage clients to buy Royal Canin Veterinary Care Nutrition (VCN) pet food.
Veterinary Marketing Manager, Lindsay Calcraft, said: "Customers who purchase any 1.5kg bag of feline VCN or any 3.5kg bag of canine VCN from their vet will receive a cat activity ball or a leashpod to thank them for their custom and support.
"For those who don't know what a leashpod is, it's a fantastic dog lead handle to help you carry all those essential items needed for walking a dog. It has an integrated bag dispenser, its own scented mini bin for storing smelly used bags and two secure pockets for treats, keys, money or your mobile phone."
For more information about the Christmas promotion, visit www.royalcanin.co.uk or contact your Veterinary Business Manager.
A new animal welfare report by the PDSA has revealed that millions of pets are more aggressive, overweight and misunderstood than ever due to fundamental gaps in pet owners' animal welfare knowledge.
The PDSA Animal Wellbeing (PAW) report, which captures the views of pet owners, the veterinary profession and children, reveals that 1.3 million dogs across the UK are displaying problem behaviour. It also highlights the consequences of an obesity epidemic affecting 18.5 million dogs, cats and rabbits, and draws attention to the 11.2 million pets not registered with a vet and therefore at risk of disease due to not being vaccinated or neutered.
The BVA is urging veterinary surgeons and nurses to read the report which identifies where owners are misinformed or unaware and highlights areas that everyone can work on with their clients to help achieve better wellbeing for pets.
Peter Jones, President of the BVA, said: "This is another excellent report from the PDSA offering real insight into clients' motivations. Understanding what drives owners' attitudes, as well as helping them to understand key health and welfare issues, should help us to clarify misconceptions in the consulting room and hopefully change behaviour at home.
"On the positive side, with pet obesity ever rising it is good to see that there is a slight increase in the proportion of owners starting to recognise obesity in their pets. This is, no doubt, in part due to the tireless work of charities like the PDSA and the veterinary profession as a whole.
"Sadly, despite most owners' awareness of the ill effect that bad nutrition has on their pet this has not led to them cutting out pet treats. The fact that few can identify a healthy body shape shows that much remains to be done.
"The section on preventive healthcare remains worrying with many owners seemingly not believing in the concepts of microchipping, neutering and vaccination. Vets have a real responsibility to help communicate these issues to the pet owning public for the benefit of both clients and their animals.
"The report very clearly identifies where owners are misinformed or unaware and highlights areas that vets in practice can work on with their clients to help achieve better wellbeing for pets.
"The report is very clearly laid out and well worth a read. We would encourage all vets to take a look and identify any new educational resources to promote in the practice, in newsletters and on websites in addition to the ones they already make available to clients. The AWF leaflets, the PDSA's own website, and the Education Alliance are all good starting points."
Click here for the report.
The RCVS has announced a number of senior staff changes.
Gordon Hockey has been ratified by Council as Head of Legal Services and Registrar. This is a new role created when the post of Registrar and Secretary was split into two: Chief Executive and Secretary; and Head of Legal Services and Registrar.
Gordon, who was previously Assistant Registrar/Head of Professional Conduct, and then Acting Registrar, will have oversight responsibility for registration and professional conduct.
At the same time, Eleanor Ferguson, formerly Acting Head of Professional Conduct, has been confirmed in the position.
The post of Head of Registration has been made redundant, with a new role of Customer Experience Manager created to ensure that the customer (public and profession) journey improves across the organisation. This position will also report into Gordon Hockey.
There have been other changes on the Senior Team at the College. The post of Head of Corporate Services that had been vacant since the departure of Richard Holford last December will not be filled, and Head of Finance Corrie McCann has been promoted to the new role of Head of Operations, which will incorporate finance, corporate services (IT, mailing, reception) and facilities.
Two other posts have been made redundant: Special Projects Manager and RCVS Charitable Trust Director. A new post of Executive Director for the Trust will be developed, with a view to taking the Trust through a full strategic review.
Chief Executive Nick Stace said: "I believe that an engaged and well-purposed team of staff, with a focus on customer service and driving improvements, lies at the heart of any successful organisation. These changes will enable the College to move into the next stage of its development towards becoming a first-rate regulator."
The changes will mean that the Senior Team is reduced from 11 people to seven, being the Chief Executive plus Heads of Legal Services, Operations, Human Resources, Education, Veterinary Nursing and Communications.
Following a new study published in the journal Emerging Infectious Diseases, the World Small Animal Veterinary Association's One Health Committee has called for a co-ordinated global infectious disease monitoring system to be established for veterinarians who work in small companion animal practice worldwide.
The study, led by Michael Day, Professor of Veterinary Pathology in the School of Veterinary Sciences at the University of Bristol and Chair of the WSAVA's One Health Committee, lists the key zoonotic diseases of cats and dogs.
It recommends that the knowledge gained through surveillance would permit more effective global control of small companion animal zoonoses and reduce the risks associated with the human-animal relationship.
Professor Day said: "It is well recognised that most of the major new diseases of mankind will have an animal origin and that dogs and cats are a potential source of such emerging diseases.
"The number of small companion animals is particularly significant. For example there are an estimated eight to ten million dogs living in up to 31 per cent of UK homes and in the USA, 72 million dogs in 37 per cent of homes. The benefits of pet ownership on human health, well-being and development are unquestionable but, as they have moved from the barn, to the house, to the bedroom, the potential for disease spread to humans increases. Control of diseases among dogs and cats is a good way to prevent spread to humans.
"In human, livestock and wildlife heath there are already programmes of active surveillance for infectious disease underway to monitor the global distribution and movement of key infectious agents. For example, the WHO monitors human influenza virus infection through a network of 111 centres in 83 countries. In contrast, there is no such monitoring for the infections that may be transmitted between small companion animals and man. Meanwhile, canine rabies virus infection, one of the diseases listed in the paper, is estimated to kill a minimum of 55,000 people in Africa and Asia each year.
"The development of such a scheme would require the significant political will, scientific application and financial support that could be achieved through a public-private partnership. The aim of our position paper in Emerging Infectious Diseases is to initiate stakeholder discussions with that end goal in mind."
Kruuse has announced that it is now the exclusive veterinary distributor in the UK, Europe, Australia and New Zealand for Nurtured Pets' Anti-LickStrip pet plaster, a natural hypo-allergenic adhesive plaster that deters licking, biting and chewing.
Anti-LickStrip's plaster is made with active ingredients including cayenne pepper, oregano, lemon powder and peppermint that acts as a deterrent to the animal when sniffed, licked or bitten. The veterinary range of Anti-Lick products will be co-branded under the Kruuse 'Buster' brand as: Buster Anti-LickStrip (sizes: small, medium and large) Buster Anti-LickStrip Pro and Buster Anti-LickStrip Pro C.
Andrew Groom, Managing Director, Kruuse UK Ltd. said: "This agreement further expands Kruuse's small animal product portfolio with its customer in Scandinavia, mainland Europe and the UK; increasing the already extensive range of animal tamper deterrents available to the veterinary practitioner."
Lisa Huntsman, President, Lauren Manufacturing & Nurtured Pets said: "This exciting partnership will further expand our products presence within the veterinary industry expanding our delivery of focused health and wellness products to customers, using Kruuse's strong relationships within veterinary practices."
In the last four years, there has been an increase in the number of identified B. canis cases in the UK, which had previously been sporadic and isolated.
Data released by the Government shows that cases have risen from three reported before 2020 to 240 in the last three years.
Most dogs were either imported, had returned from holiday overseas, or been bred with an imported dog.
In 2022, the first UK case of dog-to-human transmission was reported, highlighting the risks to those handling and treating infected dogs and raising levels of concern within veterinary teams, although the BVA says the risk is relatively low.
The BVA, SPVS and BVNA joint policy calls on the Government to :
British Veterinary Association President Anna Judson said: “Vets are seriously concerned about the lack of adequate checks for potentially zoonotic diseases entering the country via imported dogs.
"Brucella canis is not currently considered to be widespread in the UK, so a proactive approach with an emphasis on reducing the risk of this and other worrying exotic diseases being brought into the UK is crucial.
“This is important both for the health of the UK’s dogs and the humans who care for them."
https://www.bva.co.uk/take-action/our-policies/brucella-canis
Nominations are now being sought for candidates to stand in the Royal College of Veterinary Surgeons Council and Veterinary Nurse Council (VN Council) elections. The deadline for nominations is 5pm on 31 January 2013.
Nick Stace, RCVS Chief Executive said: "Last year, a record number of veterinary surgeons showed by seeking a seat on RCVS Council that they were willing to help regulate their profession. The RCVS needs the efforts of willing vets and VNs to ensure that their professions continue to be well regulated. If you've thought about standing 'someday' - why not make someday now?"
There are six seats due to be filled on RCVS Council, and two on VN Council. Those elected will take their seats on RCVS Day next July, to serve four-year terms. Council members will be expected to spend at least six to eight days a year attending Council and Committee meetings, working parties and subcommittees (for which a loss-of-earnings allowance is available).
Each candidate needs to find two proposers; any veterinary surgeon or veterinary nurse (who is not presently on either Council) may propose one candidate for RCVS or VN Council respectively.
Nomination forms, full instructions and guidance notes are available from www.rcvs.org.uk/rcvscouncil13 and www.rcvs.org.uk/vncouncil13.
For the first time this year the RCVS will organise a webinar-style hustings event for RCVS Council candidates during the election period. This will offer candidates the opportunity to outline his or her manifesto verbally in a live event, with an audio-only recording. It will not be compulsory for candidates to take part, although it is hoped that the event will enable candidates to make their points in a way that will engage a broader range of voters than the paper manifestos alone.
The RCVS is reminding all veterinary nurses intending to remain on its List/Register of Veterinary Nurses that it needs to receive any outstanding retention fees on or before 31 December.
The College says it will be writing to all VNs whose fees have not yet been received, and will not remove anyone from the List/Register whose fees have been paid and cleared by 31 December.
You can pay your fees online using the individual log-in numbers on the fee letters sent in October.
If you have mislaid your log-in number, you can email webadmin@rcvs.org.uk, including your full name, date of birth, address on the Register/List, and badge number (engraved on the back of your VN badge). Payments can also be made by bank transfer, using the details from the fee letter. If paying by cheque, please write your name and Register/List number on the back. Cheques need to be received by the RCVS before 21 December, and the payment to have cleared by 31 December. The retention fee for veterinary nurses is due annually by 1 November.
The Kennel Club Genetics Centre at the AHT has identified a genetic mutation which causes a severe progressive disease in Parson Russell Terriers (PRTs).
Late onset ataxia (LOA) affects coordination and balance, making everyday movement and tasks increasingly difficult. The new DNA test can accurately predict the risk of developing the disease in 97-100 per cent of PRTs and will effectively reduce the number of LOA cases in the breed.
Dogs usually develop the disease between six months and one year of age but because there is no cure, sufferers are usually euthanised around two years after onset as their quality of life diminishes.
After testing DNA of over 200 PRTs in total, the AHT's scientists were able to isolate the genetic mutation which causes the disease and establish that LOA is an inherited recessive trait; therefore dogs must have two defective copies of the genetic mutation, one from each parent, to be affected.
The test results will inform dog owners if their dog is clear from, a carrier of, or affected by LOA.
Cathryn Mellersh, Head of Canine Genetics, at the AHT said: "This is great news for PRT breeders as we believe LOA is an emerging condition in the breed and through this test we should be able to cut the disorder 'off at the pass', before the mutation becomes any more widespread.
"Interestingly, our research also suggests that there may be other causes of ataxia in the breed. It is important for breeders to understand that a clear result using the LOA DNA test will not exclude the formal possibility that dogs could still develop a genetically different form of ataxia."
Caroline Kisko, Kennel Club Secretary, said: "LOA is a relatively new but devastating condition and we are delighted that we've been able to work with the Animal Health Trust to develop a DNA test that will give breeders the opportunity to significantly reduce this disease. We will keep working together to develop tools and information for breeders, so that they are able to select dogs that will have healthy puppies."
The DNA test for LOA is available from the AHT at the price of £48. Full details are available at www.ahtdnatesting.co.uk.
Axiom Veterinary Laboratories has launched SLIT - sublingual immunotherapy treatment - for allergies in cats, dogs and horses.
According to the company, sublingual immunotherapy has been shown to be safe and effective in humans for over 20 years and a recent study has shown it to be a beneficial alternative way of administering immunotherapy to cats, dogs and horses, proving particularly effective in treating animals that failed to respond to allergy shots.
Patients can convert from shots to drops with an initial treatment kit.
Martyn Carpenter, Director of Axiom Laboratories Ltd, said: "Each ACTT Allergy Drop prescription is a custom formulation containing the specific allergens that are causing the pet's discomfort. Allergy drops are prepared in a glycerin solution to provide antigen stability, and have a slightly sweet taste, which assists in palatability and ease of administration. This method greatly reduces irritation and the likelihood of anaphylactic shock and can be administered easily at home by the client, freeing up consult slots and removing the stress which accompanies a visit to the surgery for many pets. This can be a particularly suitable alternative for those clients on a restricted budget, for whom on-going consult and injecting fees can be prohibitive to compliance with immunotherapy treatment. "
For more information, contact Axiom's Diagnostic Support Team on 01626 355655
Rimifin (carprofen), an NSAID marketed by Vetoquinol, has been given a new flavour to help increase compliance.
Robert Simpson, Product Manager for Rimifin said: "Pet owner compliance and involvement in chronic pain situations is critical to ensuring effective long term treatment. Ease of administration is also very important in this setting. The addition of this flavouring to this popular and cost effective NSAID will help to ensure that administration to the patient is as easy as possible for pet owners and vets."
To find out more about Rimifin please contact your Vetoquinol Territory Manager or call 01280 825424.
The new, four storey, architecturally-designed clinic is full of natural light and includes calming and spacious staff breakout areas.
By combining a beautiful work environment with seamless technology, the company believes it can transform working conditions and job satisfaction for vet teams.
On the tech side, the Creature Comforts has created a proprietary app which allows triage to be handled online and for staff to work flexibly.
The company says the app also reduces the administrative burden, a contributory factor for staff burnout.
Creature Comforts says most clients subscribe at a cost of £20 per pet per month, giving them unlimited consultations, instant bookings and live chat via the app (as well as annual vaccinations and discounted routine treatments).
This should mean animals are seen more frequently, and conditions can be identified and treated earlier.
Memberships will be capped to control vet team caseload and to ensure a good customer experience.
The company is also addressing Competition and Markets Authority concerns, with prices for routine treatments listed on its website, upfront estimates for procedures, and a business model hinged on unlimited access to expertise (i.e. consultations, instant in-app bookings and live chat) at no extra cost for subscribed members.
Creature Comforts says its vet team benefits from a share of their clinic’s profits, above industry-standard pay, compensated overtime, a well-balanced staffing ratio, manageable working hours and scheduled breaks.
Dr Russell Welsh, COO and co-founder of Creature Comforts, said: “It’s an incredible feeling to see a plan come together in a sector that’s so ripe for transformation.
"We want to bring the passion, joy and fun back to our profession, and this is an opportunity to do things differently and vastly better, with a fresh and carefully-considered business model founded on the principles of health and happiness.
"This is vet care as it should be."
https://www.creaturecomforts.co.uk
The response offers further evidence concerning the CMA’s potential concerns, and says that voluntary measures relating to transparency of fees and ownership could be introduced before the conclusion of a market investigation.
The BVA has formed a working group to develop guidance on transparency, client choice and the value of veterinary care to support companion animal practices.
British Veterinary Association President Anna Judson, said: “We’re keen to see healthy competition and consumer choice and we recognise that some of the areas identified by the CMA would benefit from further scrutiny.
"We are already taking steps to support vet practices by developing guidance for the profession in relation to transparency of fees, transparency of ownership, prescribing and dispensing of veterinary medicines, and contextualised care.
“However, we are extremely disappointed to see the suggestion in the CMA’s report, as well as in subsequent media reporting, that veterinary professionals might prey on owners’ desire to do the best for their pets by using these circumstances as a “strategy” to promote more sophisticated or expensive treatment.
"Vets enter this high-pressure profession out of genuine care for animals and will always prioritise their health and welfare."
“We also have significant concerns about the suggestion that practices might be mandated to provide information to clients about quality or outcome-related measures.
"We do not see primary concerns about the quality of veterinary treatment and we believe such a requirement would not meaningfully support consumer choice.
"Instead, it would be extremely challenging to deliver and could significantly exacerbate many of the complex issues faced by our members, who are already under significant pressure.
There will be a panel discussion about the CMA investigation at BVA Live this year.
https://bvalive.vetshow.com
COMMENT
There are lots of good points made in this latest response to the CMA, if no more than a nod to the real issue here: which is the often eye-watering cost of modern veterinary care.
But it is hugely disappointing to see the BVA (and others) berating the CMA and the media for suggesting that vets might prey on owners' desire to do the best for their pet, rather than asking WHY people think that, and how can the profession regain trust.
That, surely, is the starting point here: for the profession to stop feeling sorry for itself, and instead think how it can change to meet the needs of its customers and dispel their perception of being taken for a ride.
The CMA Investigation is a bit of a red herring: the price of veterinary care is not going to be significantly changed by displaying the prices for a few standard procedures on practice websites, with greater transparency over practice ownership or with slightly cheaper prescriptions, all of which is just tinkering.
The biggest influence on the size of the client's bill is not marketplace competition, it's the vet's recommendation.
Paul Manktelow, Chief Vet at the Blue Cross has already hit the nail square on the head when he called on the profession to practise pragmatic medicine.
The BVA now alludes to this with talk in its response of 'contextualised care' - a concept which allows practitioners to offer pragmatic medicine (aka what people can afford, rather than 'gold standard'), without the judgement that it is inherently associated with).
The benefits of 'contextualised care' are well explained by Ruth Serlin at VDS Training here.
That's great, but will it be enough?
Perhaps not, because whilst someone might be happy to walk out of the car showroom with a Dacia Sandero knowing they cannot afford a Bentley, they may be less happy to accept the Dacia level of care for their beloved pet, when they watched 'Supervet' only the night before.
If that's true, then pragmatic medicine will have to be combined with all sorts of other measures, such as reviewing and reducing the cost of regulation, questioning the value of diagnostics and changing to a less 'referall' (sic) culture.
Ceva Animal Health has announced the launch of Cardalis for the treatment of canine heart failure caused by degenerative valvular heart disease.
Cardalis contains what the company says is a unique combination of benazepril and spironolactone in one tablet which provides "dual blockade" of the RAAS system.
Benazepril reduces the production of angiotensin II, which causes narrowing of the blood vessels, while spironolactone blocks the harmful effects of aldosterone, which include cardiovascular remodelling and fibrosis.
Cardalis tablets are small, beef flavoured and designed to be administered once a day with food. Each pot contains 30 tablets and there are three sizes available. Ceva says it should be given as part of standard heart failure therapy as soon as clinical signs, such as exercise intolerance, coughing or dyspnoea, appear.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "Through our clinical studies, it has been found that dogs receiving benazepril and spironolactone (compared with benazepril alone) have a better quality of life and, at any one time, are three times less likely to die from heart failure.
"We have also assessed 101 dogs in a field study that were prescribed Cardalis for three months, followed by separate benazepril and spironolactone tablets for two weeks. In the study, 97 per cent of dog owners found Cardalis easier to administer than the two separate tablets and 89 per cent of vets found Cardalis easier to prescribe."
For further information about Cardalis, or to receive marketing materials for the product (which include a waiting room poster and client information booklets), visit www.ceva.com.uk, or contact the practice support team on 01494 781510.
The badger culls planned to take place in West Somerset and West Gloucestershire this year have been postponed until 2013.
The postponement came at the request of The National Farmers Union (NFU), following new survey results which revealed higher than anticipated badger numbers in the two pilot areas (4,300 in West Somerset and 3,600 in West Gloucestershire ).
The NFU informed Defra that in light of these new figures they could not be confident of removing the required minimum 70% of the badgers in the two pilot areas this autumn.
Defra agreed to postpone the pilot culls until summer 2013 to allow farmers to continue their preparations and have the best possible chance of carrying out the cull effectively.
Environment Secretary Owen Paterson said: "Despite a greatly increased effort over the last few days and weeks, the farmers delivering this policy have concluded that they cannot be confident that it will be possible to remove enough badgers based on these higher numbers and considering the lateness of the season. It would be wrong to go ahead if those on the ground cannot be confident of removing at least 70% of the populations. Today I have received a letter from the President of the NFU, on behalf of the companies coordinating the culls, explaining why they do not feel they can go ahead this year and requesting that they be postponed until next summer. In these circumstances, it is the right thing to do and, as the people who have to deliver this policy on the ground and work within the science, I respect their decision.
"The Government is determined to tackle bovine TB by all the means available to us. Now, in the next few months, we will ensure that the pilot culls can be implemented effectively, in the best possible conditions, with the right resources. Having looked at all the evidence over many years, I am utterly convinced that badger control is the right thing to do, and indeed the higher than expected badger numbers only serve to underline the need for urgent action. I remain fully committed to working with the farming industry to ensure that the pilot culls can be delivered effectively, safely and humanely next summer."
The Government and NFU say they will now continue to plan so that the pilots can go ahead in Summer 2013.
Ceva Animal Health has launched Cystease Advanced, a new urinary tract support supplement for cats.
The new product, which contains N-acetyl glucosamine, L-tryptophan and Hyaluronic Acid, is described as an elaboration on the original product, Cystease S.
Ceva says Cystease Advanced has been designed to help support the bladder lining while also reducing stress-related behaviour in cats.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "It is well documented that stress can adversely affect the integrity of the bladder lining. There are many factors that cause stress in cats, for example inter-cat conflict, moving house, new arrivals to the home environment and car travel, to name just a few.
"Our new product has been developed to address both conditions; it contains N-acetyl glucosamine and Hyaluronic Acid which are key components of the GAG lining, whereas L-tryptophan has been proven to reduce stress-related behaviour in cats."
Cystease Advanced is taken orally and is available in pots of 30 and 300 tablets.
Ceva recommends that Cystease Advanced is used with Feliway, the company's appeasing pheromone for cats.
For further details please contact the customer support team on 01494 781510.
Petplan has announced that nominations are now open for its 14th annual Veterinary Awards.
The awards recognise members of the veterinary community who have gone above and beyond in their daily role.
According to the company, one in three pets make an unexpected trip to the vet each year, making vets the unofficial 4th emergency service. A quarter of pet owners consider their vet a good friend with 42% on first name terms. 98% of Petplan customers have said that they trust their vet; with many saying that they are more trustworthy than police officers - coming second only to doctors.
Petplan's Head of Marketing, Isabella Von Mesterhazy said: "At Petplan, we hear from our customers every day about the exceptional service veterinary staff have given to pets in their care. The Veterinary Awards are an opportunity for Petplan to show our support to members of this profession and thank these hard-working individuals on a national scale. We want to encourage pet owners across the UK to nominate their veterinary stars this year to show their appreciation for all their tireless effort to keep the nations pets fit and healthy."
To make nominate a vet, vet nurse, vet practice and other members of the veterinary team visit www.petplan.co.uk/vetawards before 31st January 2013. The winners will be announced at the ceremony held in Birmingham on 4th April 2013.
Kruuse has announced that it is to become the exclusive veterinary distributor in Europe for Kit4Cat, a globally patented hydrophobic sand for veterinary use.
Kit4Cat is a biodegradable sand with a natural non-toxic urine repelling coating which allows veterinary surgeons, veterinary nurses and cat owners to collect a urine sample for urinalysis without resorting to more invasive procedures. Kit4Cat is put in the cat's normal litter tray, whereupon it repels rather than absorbs the urine, allowing it to be collected with a pipette.
Andrew Groom, Managing Director, Kruuse UK Ltd., said: "This exciting agreement and product range further expands Kruuse's small animal product portfolio with its customers in Scandinavia, mainland Europe and the UK; increasing the already extensive range of feline products available to the veterinary practitioner."
Daniel Levitt, BA, MSM, CEO, Co-Founder & Board Member of Coastline Global, the makers of Kit4Cat, said: "This agreement will further expand our products presence within the veterinary industry, using Kruuse's strong relationships within veterinary practices, to promote less stressful ways of urine test collection prior to diagnosis and treatment of cats."
Bayer Animal Health has produced a take home prescription guide to encourage pet owners to remain compliant with its antimicrobial, Veraflox (pradofloxacin).
The leaflet contains prescription details together with a treatment record and next appointment reminder. Group Product Manager Tracey Dawson said: "There is also a FAQ (frequently asked questions) section explaining why compliance is so important."
Bayer says the leaflet has been developed to help vets and VNs ensure pet owners are encouraged to be responsible with prescribed medicines. Tracey added: "The guide is designed to reinforce the information given by the prescribing vet, and answer further questions owners might have on arrival home or during the treatment."
Bayer highlights that Veraflox's mode of action helps reduce the potential for the development of resistant bacteria¹, but only if it is used correctly. Tracey said: "Although it might seem to be easy for pet owners to adhere to the advice given with prescribed medicines, especially with the more palatable options now available, it is very important that we help preserve the efficacy of the fluoroquinolone class by continuing to encourage strict client compliance through correct dosing, and finishing the course of antibiotics prescribed."
For further information, contact your Bayer Territory Manager or call Bayer Animal Health on 01635 563000.
Wetzstein HG. Comparative Mutant Prevention Concentrations of Pradofloxacin and Other Veterinary Fluoroquinolones Indicate Differing Potentials in Preventing Selection of Resistance. Antimicrob Agents Chemother. 2005;49(10): 4166-4173
HRH The Princess Royal has opened the Animal Health Trust's new cancer treatment and research facility in Suffolk.
The facility has been purpose-built to treat horses, dogs and cats with cancer. It will also assist in furthering understanding of the disease in animals.
Peter Webbon, Chief Executive of the AHT, said: "2012 marks 70 years of the AHT fighting disease and injury in animals, and the addition of the Cancer Centre is a landmark achievement in our history. We believe this is the first facility of its kind in Europe, purpose-built to treat horses, dogs and cats with cancer. We now have a short commissioning process to undertake but anticipate welcoming the first patients through the doors in early 2013."
The Kennel Club Cancer Centre at the AHT houses a linear accelerator (pictured right) and brachytherapy machine used in radiotherapy treatment, along with a 16-slice CT scanner to aid radiotherapy planning.
The new facility complements the AHT's existing cancer treatment options of surgery and chemotherapy meaning the Suffolk-based charity will be able to offer each and every patient the very best options for their specific case, whatever the diagnosis. With one in four dogs and one in six cats developing cancer at some time in their life the new centre will help many more animals fight cancer.
Peter Webbon, added: "It was thanks to a generous donation from the late Tom Scott, a long-term supporter of the AHT, that we were able to start this development. His donation, along with that from many other AHT supporters, and an interest-free loan of £1.5 million from the Kennel Club has meant this ambitious project has come to fruition so quickly."
It has taken just over a year to build the Cancer Centre which contains more than 2,600 tonnes of concrete and has eight-feet wide solid concrete walls.
On opening the facility, HRH The Princess Royal, President of the AHT, said: "This Cancer Centre is an exciting development at the AHT and will make a real difference for animals with cancer, here and now. It will improve the chances, for many animals, of beating this pernicious disease.
"Countless other horses, dogs and cats across the world with cancer, who will never be seen by an AHT clinician, will also benefit from knowledge gained from research in The Kennel Club Cancer Centre at the AHT."
The AHT has a strong history in cancer research and the Kennel Club Cancer Centre will enhance the charity's well established cancer research programme. Knowledge gained through the treatment of animals in the facility will contribute to the study of cancers, their causes, early diagnosis and treatment, and ultimately hopefully the prevention of some forms of the disease.
Steve Dean, Kennel Club Chairman, said: "I am very proud to be here today to celebrate the opening of the Kennel Club Cancer Centre. Thanks to the expertise available here at the Animal Health Trust, the Cancer Centre will provide advanced techniques for the diagnosis and treatment of cancer, to the benefit of many animals. It is exciting to consider how synergy between the Kennel Club Cancer Centre and the Kennel Club Genetics Centre can help to further the understanding of the inheritance factors that influence the development of cancer."